Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Flynn

Showing results (461-470 of 499) with videos related to

Pageof 50
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
JCI Insight|February 23, 2026
Antiretroviral treatment does not prevent extrapulmonary tuberculosis during SIV/Mtb coinfection in macaquesCollin R Diedrich, Tara Rutledge, Janelle L Gleim, et al.
Infection and Immunity|May 30, 2013
Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus)Laura E Via, Danielle M Weiner, Daniel Schimel, et al.
Cell Systems|November 6, 2024
Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaquesShu Wang, Amy J Myers, Edward B Irvine, et al.
Molecular Cancer Therapeutics|August 26, 2017
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2<sup>Hi</sup> Macrophages in Breast Cancer and Pancreatic Neuroendocrine TumorsAllison S Harney, George S Karagiannis, Jeanine Pignatelli, et al.
Molecular Oncology|March 20, 2024
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacyYasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, et al.
Cancers|March 10, 2022
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor ProgressionYvonne E Smith, Guannan Wang, Ciara L Flynn, et al.
Molecular Cancer Therapeutics|October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic CancerRyan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.
Immunity|August 30, 2024
CD4<sup>+</sup> T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfectionJoshua D Bromley, Sharie Keanne C Ganchua, Sarah K Nyquist, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Development of an Engineered <i>Mycobacterium tuberculosis</i> Strain for a Safe and Effective Tuberculosis Human Challenge ModelXin Wang, Hongwei Su, Joshua B Wallach, et al.
Pageof 50

Showing results (461-470 of 499) with videos related to

Sort By:
Pageof 50
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
JCI Insight|February 23, 2026
Antiretroviral treatment does not prevent extrapulmonary tuberculosis during SIV/Mtb coinfection in macaquesCollin R Diedrich, Tara Rutledge, Janelle L Gleim, et al.
Infection and Immunity|May 30, 2013
Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus)Laura E Via, Danielle M Weiner, Daniel Schimel, et al.
Cell Systems|November 6, 2024
Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaquesShu Wang, Amy J Myers, Edward B Irvine, et al.
Molecular Cancer Therapeutics|August 26, 2017
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2<sup>Hi</sup> Macrophages in Breast Cancer and Pancreatic Neuroendocrine TumorsAllison S Harney, George S Karagiannis, Jeanine Pignatelli, et al.
Molecular Oncology|March 20, 2024
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacyYasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, et al.
Cancers|March 10, 2022
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor ProgressionYvonne E Smith, Guannan Wang, Ciara L Flynn, et al.
Molecular Cancer Therapeutics|October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic CancerRyan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.
Immunity|August 30, 2024
CD4<sup>+</sup> T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfectionJoshua D Bromley, Sharie Keanne C Ganchua, Sarah K Nyquist, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Development of an Engineered <i>Mycobacterium tuberculosis</i> Strain for a Safe and Effective Tuberculosis Human Challenge ModelXin Wang, Hongwei Su, Joshua B Wallach, et al.
Pageof 50